title: Does reimbursement affect physicians' decision making? Examples from the use of recombinant erythropoietin.
authors.affiliation: Division of Geriatrics, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.
authors.forename: June M
authors.initials: JM
authors.lastname: McKoy
authors.forename: Cara C
authors.initials: CC
authors.lastname: Tigue
authors.forename: Charles L
authors.initials: CL
authors.lastname: Bennett
mesh_terms: D000740:Anemia / Q000188:drug therapy* / Q000209:etiology; D003657:Decision Making / Q000941:ethics; D004921:Erythropoietin / Q000191:economics* / Q000627:therapeutic use; D015276:Health Care Rationing / Q000941:ethics; D006397:Hematinics / Q000191:economics* / Q000627:therapeutic use; D006801:Humans; D007349:Insurance, Health, Reimbursement; D009369:Neoplasms / Q000150:complications*; D018579:Patient Selection / Q000941:ethics*; D017410:Practice Guidelines as Topic; D010818:Practice Patterns, Physicians' / Q000191:economics* / Q000941:ethics; D011994:Recombinant Proteins; D014481:United States
chemical_list: D006397:Hematinics; D011994:Recombinant Proteins; D004921:Erythropoietin